We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 143.00 | 151.00 | 170.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/6/2016 16:06 | Looks to me that it could go lower than 16p in the short term. Good future prospects for AMYT, but I can't see the share doing anything in the short term. General Mkt conditions not good and good news not likely until 2017. | papillon | |
16/6/2016 15:22 | 16p vs the reverse takeover share price looks like an opportunity to me, assuming things unfold in the future as per the general Business Plan | pottermagic2310 | |
16/6/2016 14:59 | It's knocking all of mine :-( | bigwavedave | |
16/6/2016 14:03 | EU vote knocking most of my shares | currypasty | |
16/6/2016 13:37 | Well, this is looking miserable again. For those of us who hold, I guess it'll just have to be a case of waiting for the Summer/Autumn newsflow. | bigwavedave | |
13/6/2016 11:19 | Proactive interview: | flyingswan | |
13/6/2016 10:52 | Amryt Pharma chief looking to “unlock a large market opportunity” | bigwavedave | |
10/6/2016 11:05 | They won't let me post the link. But it's at proactive investors website under Beaufort Securities Breakfast Alert. | bigwavedave | |
10/6/2016 11:03 | Beaufort Securities: "Furthermore, as soon as the Amryt phase three trial of Episalvan for Epidermolysis Bullosa gets under way then Amryt is going to be of even more interest to these multinational pharmaceutical companies. In view of the potential sales for Orphan drugs, and the interest from Big Pharma, we recommend as a Speculative Buy." [...] | bigwavedave | |
10/6/2016 08:53 | I certainly don't read too much into these Results. They're far too reflective of the failing/failed FASTNET O&G/EQUITY Businesses and nothing much to do with the new Company we're now invested in. The Report had to be produced and is very reflective of that legacy situation. I'm far more interested in the current Business Plan for this new Business and some sort of realistic Forecast for the next 18-24 months. | pottermagic2310 | |
10/6/2016 08:32 | results were pre reverse takeover, ended December. still has £10m cash | currypasty | |
09/6/2016 17:42 | Seems like the Amyt catch word is, loss, as it is prevalent throughout the account RNS. | jacksonpollack | |
09/6/2016 14:39 | Did anyone listen in on the conf call? I was away. Nothing on the link now. I assume no revelations. | bigwavedave | |
09/6/2016 07:44 | one day ill be in profit on those old fast shares | currypasty | |
09/6/2016 07:42 | Keep buying Currypasty . You know you want to . | talkman2 | |
09/6/2016 07:33 | Another addition to the management team from Shire, Michele Belindi | alphabravo321 | |
08/6/2016 13:57 | Too late. Back to conventional pricing! Hopefully we'll get some good new news tomorrow. | bigwavedave | |
08/6/2016 12:57 | bargain, get 10 million, then sell straight away | currypasty | |
08/6/2016 12:08 | On TDDirect, I can sell these for 18.7751 or buy them for 18.7p. Very odd. | bigwavedave |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions